11/12/2024
6:05 AM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
9:52 AM | Syndax Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/05/2024
3:02 PM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:03 PM | Syndax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
10:49 AM | STATE STREET CORP (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SC 13G/A | |
06/17/2024
8:26 AM | Goldan Keith A. (Reporting)
Syndax Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:03 AM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:04 AM | Syndax Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/18/2024
6:10 AM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
4:21 PM | Syndax Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
4:28 PM | Syndax Pharmaceuticals (Filer)
| Form S-3ASR | |
02/27/2024
3:33 PM | Syndax Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
11:50 AM | Kynam Capital Management, LP (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SC 13G | |
02/14/2024
6:01 AM | Point72 Asset Management, L.P. (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
8:44 PM | Avidity Partners Management LP (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
9:18 AM | Syndax Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/25/2024
10:20 AM | STATE STREET CORP (Filed by)
Syndax Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/20/2023
7:40 AM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
4:29 PM | Syndax Pharmaceuticals (Filer)
| Form 424B5 | |
12/15/2023
4:29 PM | Syndax Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
3:30 PM | Syndax Pharmaceuticals (Filer)
| Form 424B5 | |
